ZBP1 and TRIF trigger lethal necroptosis in mice lacking caspase-8 and TNFR1

Author:

Solon Margaret,Ge Nianfeng,Hambro Shannon,Haller Susan,Jiang Jian,Baca Miriam,Preston Jessica,Maltzman Allie,Wickliffe Katherine E.,Liang Yuxin,Reja Rohit,Nickles Dorothee,Newton Kim,Webster Joshua D.ORCID

Abstract

AbstractNecroptosis is a lytic form of cell death that is mediated by the kinase RIPK3 and the pseudokinase MLKL when caspase-8 is inhibited downstream of death receptors, toll-like receptor 3 (TLR3), TLR4, and the intracellular Z-form nucleic acid sensor ZBP1. Oligomerization and activation of RIPK3 is driven by interactions with the kinase RIPK1, the TLR adaptor TRIF, or ZBP1. In this study, we use immunohistochemistry (IHC) and in situ hybridization (ISH) assays to generate a tissue atlas characterizing RIPK1, RIPK3, Mlkl, and ZBP1 expression in mouse tissues. RIPK1, RIPK3, and Mlkl were co-expressed in most immune cell populations, endothelial cells, and many barrier epithelia. ZBP1 was expressed in many immune populations, but had more variable expression in epithelia compared to RIPK1, RIPK3, and Mlkl. Intriguingly, expression of ZBP1 was elevated in Casp8−/−Tnfr1−/− embryos prior to their succumbing to aberrant necroptosis around embryonic day 15 (E15). ZBP1 contributed to this embryonic lethality because rare Casp8−/−Tnfr1−/−Zbp1−/− mice survived until after birth. Necroptosis mediated by TRIF contributed to the demise of Casp8−/−Tnfr1−/−Zbp1−/− pups in the perinatal period. Of note, Casp8−/−Tnfr1−/−Trif−/−Zbp1−/− mice exhibited autoinflammation and morbidity, typically within 5–7 weeks of being born, which is not seen in Casp8−/−Ripk1−/−Trif−/−Zbp1−/−, Casp8−/−Ripk3−/−, or Casp8−/−Mlkl−/− mice. Therefore, after birth, loss of caspase-8 probably unleashes RIPK1-dependent necroptosis driven by death receptors other than TNFR1.

Publisher

Springer Science and Business Media LLC

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3